Abstract:Background: Cardiac allograft vasculopathy (CAV) is one of the major causes of death after heart transplantation (HTx). However, immunological mechanisms of CAV remain incompletely understood. This study aimed to determine distinct immune profiles of CAV compared to HTx patients with normal graft function (CONTROL). Methods: Peripheral blood mononuclear cells (PBMC) obtained from the International Society for Heart and Lung Transplant grade 2 or 3 CAV (n=6), and CONTROL (n=12) patients were analyzed using single cell RNA sequencing (498 genes) on the BD Rhapsody platform combined with 56 protein markers (CITE-seq) and VDJ-seq. Cells were clustered into major cell types using 18 protein markers. Targeted clustering was then performed to determine subclusters using proteomic and transcriptomic data. Results: Proportions of memory B cell (0.5±0.4% vs 1.4±0.8%, p=0.01) and CD16+CD56+ TEMRA CD8 T cell (0.5±0.3% vs 1.0±1.7%, p=0.007) were decreased and proportion of C1q+ nonclassical monocyte (1.0±0.5% vs 0.4±0.3%, p=0.01) was increased in CAV patients compared to CONTROL. In Th1 effector memory CD4 T cell cluster, CAV had a significantly higher proportion of clonally expanded cells (24.1±10.0% vs 11.3±9.2%, p=0.01) characterized by higher expression of NKG7, GZMH, CCL5, and CST7 compared to non-expanded cells in this cluster. Signature genes with the highest positive coefficients determined by LASSO regression to predict CAV (72.2% accuracy) included IFITM3, LAIR2, CD52, IFITM2, NKG7, NAMPT, CD74, F13A1, IL3RA, and RNASE2. IFITM3 and LAIR2 were the best positive predictors for CAV and overexpressed predominantly in CD4 T and CD8 T cells (Figure). Conclusion: CAV demonstrates distinct immune cellular and transcriptomic phenotypes compared to CONTROL. IFITM3 and LAIR2 overexpression in PBMCs may predict severe CAV in HTx patients.

Revisiting Biomarkers of Cardiac Allograft Vasculopathy: Addressing the Achilles Heel of Heart Transplantation

Cardiac Allograft Vasculopathy: Challenges and Advances in Invasive and Non-Invasive Diagnostic Modalities

Biomarkers for Renal Transplantation: Where Are We?

Transplant coronary heart disease: challenges and solutions

Multiparametric Cardiac Magnetic Resonance Imaging Detects Altered Myocardial Tissue and Function in Heart Transplantation Recipients Monitored for Cardiac Allograft Vasculopathy

Identification of Candidate Biomarkers in Peripheral Blood for Cardiac Allograft Rejection Based on Bioinformatics Analysis

Enhancing the Prediction of Cardiac Allograft Vasculopathy Using Intravascular Ultrasound and Machine Learning: A Proof of Concept

The role of optical coherence tomography and other intravascular imaging modalities in cardiac allograft vasculopathy

Abstract 12560: Single Cell RNA Sequencing Signature of Cardiac Allograft Vasculopathy

OCT Assessment of Allograft Vasculopathy in Heart Transplant Recipients

Heart transplantation and biomarkers: a review about their usefulness in clinical practice

Single-cell RNA-sequencing identifies unique cell-specific gene expression profiles in high-grade cardiac allograft vasculopathy

Cardiac allograft vasculopathy diagnosed by vasodilator myocardial contrast echocardiography perfusion imaging

A gentler approach to monitor for heart transplant rejection

Evaluation of Myocardial Perfusion and Immune Cell Response in Cardiac Allograft Dysfunction of Heart-Transplant Patients

Non-invasive myocardial tissue deformation and discoordination indices predict cardiac allograft vasculopathy in pediatric heart transplantation patients

Multicenter Analysis of Immune Biomarkers and Heart Transplant Outcomes: Results of the Clinical Trials in Organ Transplantation‐05 Study

Cardiac PET Myocardial Blood Flow Quantification Assessment of Early Cardiac Allograft Vasculopathy

Optical Coherence Tomography in the Assessment and Management of Cardiac Allograft Vasculopathy

The Outcome of Restrictive Cardiac Allograft Physiology in Severe Coronary Allograft Vasculopathy

Molecular Imaging of Acute Cardiac Transplant Rejection: Animal Experiments and Prospects.